Abstract Submission

To submit your abstract for Poster Presentation HERE

Deadline for submission is June 11, 2023.

Abstract Submission Guidelines

Deadline for submission is June 11, 2023.

  • Abstracts have to be submitted exclusively online. 
  • Authors can submit their abstracts for poster presentation.
  • Submitted abstracts can only be modified prior to the submission deadline.
  • The presenting author must be listed first and must be the author that submits the abstract.

Topic, Language

  • Each contribution must relate to Cerebrotendinous Xanthomatosis.
  • Abstracts must be submitted and presented in English.

Size, Content

  • The abstract is limited to 2,000 characters including spaces.
  • Abstracts must be structured as follows: Background, Case Study / Methods, Results, Discussion/Conclusion
  • The title should be written in standard sentence style with lower case letters (except first word, names, human gene names [always upper-case letters & italics], etc.).
  • The text should be grammatically suitable for publication.
  • Special characters can be included during submission.
  • Non-standard abbreviations must be defined in the text.
  • Drugs must be mentioned by generic names, not trade names.
  • Abstracts must not be used to promote specific drugs, instruments etc.
  • Submitted abstracts must provide results and not announcements; stating that “Findings will be discussed…” or similar is not acceptable.
  • The usage of special formatting should be limited. The correct replication in all media cannot be guaranteed.

Conditions, Requirements

The presenter is responsible for compliance with data protection, copyrights, ethical regulations and laws.

  • The abstract should be novel. It is acceptable to submit abstracts related to information already reported at another conference or in a journal provided that new information will also be presented. The authors should declare this during submission and make clear the new information that will be presented. Please tick the appropriate box “Parts of the data have been published previously”.
  • To secure anonymity of the review process, names and locations should not be disclosed in the abstract.

Review, Registration

  • All submitted abstracts will be reviewed by several international experts.
  • Evaluation criteria are: Aim(s) and objective(s), materials and methodology, results and conclusions.

E-mail notifications about acceptance or rejection will be sent to the presenting author subsequent to the reviewing process by June, 2023.

Poster Presentation Guidelines

  • The posters will be viewed during the coffee breaks. Poster presenters are requested to stand by the poster during this time to address questions.
  • Posters should be legible from a distance of 1-2 meters. 
  • Poster presenters are kindly requested to print their poster. 
  • The recommended size of a poster should be 85 cm wide X 160 cm high (Portrait) : 

  • Poster presenters should refer to the final program (at the conference) and note the date and number of their presentation. Please use the poster board that bears the number of your presentation as listed in the program.
  • Putting up and removing the poster is the responsibility of the presenter only.

Travel Awards

Two travel awards are available for poster presenters (covering flights, accommodation and meeting registration).

Awardees must be trainees (undergraduates, graduate students, and post-docs/fellows and residents) or Junior faculty who recently completed their education within the last 5 years.

If you meet the criteria please indicate as part of abstract submission if you would like to be considered for junior travel award.